Pharmacology Research Institute, Northridge   Report issue

For profit Phase 2
Founded: Encino CA United States (1975)
Status: No NME R&D (1975)

Organization Overview

First Clinical Trial
2005
NCT00174525
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

bapineuzumab (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1